ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,418Medicare Part D Prescriptions Filled, Including Refills

Rank: 74 out of 487

$449K Total Retail Price of All Prescriptions

Rank: 50 out of 487

321 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

21% of this provider’s 321 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 4,731 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
HYDROCODONE-ACETAMINOPHEN 341 173 S3 1 3
SIMVASTATIN 276 211 2 4
LISINOPRIL 253 180 3 5
LEVOTHYROXINE SODIUM 245 179 4 1
OMEPRAZOLE 225 165 5 2
POTASSIUM CHLORIDE 183 132 6 10
FUROSEMIDE 164 128 7 7
HYDROCHLOROTHIAZIDE 129 95 8 9
LOSARTAN POTASSIUM 126 98 9 16
METFORMIN HCL 123 70 10 8
MELOXICAM 116 70 11 26
GABAPENTIN 114 53 12 13
AMLODIPINE BESYLATE 105 68 13 6
TAMSULOSIN HCL 101 87 14 25
PREDNISONE 99 32 15 37
CARVEDILOL 99 74 15 32
PRAVASTATIN SODIUM 95 61 17 20
DONEPEZIL HCL 91 82 18 38
WARFARIN SODIUM 84 70 19 11
METHADONE HCL 81 0 S2 20 65
OXYCODONE HCL 81 38 S2 20 57
METOPROLOL SUCCINATE 81 65 20 15
METOPROLOL TARTRATE 79 33 23 17
TRAMADOL HCL 77 65 24 19
ATORVASTATIN CALCIUM 77 52 24 18
CITALOPRAM HBR 75 64 26 12
FENTANYL 70 54 S2 27 36
ISOSORBIDE MONONITRATE ER 68 41 28 79
AMITRIPTYLINE HCL 65 0 R 29 45
ALLOPURINOL 63 50 30 29
ATENOLOL 63 33 30 23
IBUPROFEN 59 28 32 78
NAMENDA 58 48 33 53
TRAZODONE HCL 58 23 33 22
SPIRIVA 58 37 33 48
ACETAMINOPHEN-CODEINE 54 49 S3 36 177
NEXIUM 53 26 37 41
FLUOXETINE HCL 52 37 38 28
CYMBALTA 50 0 39 34
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.